Congress
$1,001–$15,000
Traded Feb 25, 2025 · disclosed 30 days later
13 different filers disclosed TMO within 90 days.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 26, 2025
95 tracked managers disclosed the same change for Q4 2024. From a 13F filed Feb 26, 2025 covering holdings at Dec 31, 2024 — a quarter-end snapshot, not a live trade.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
Reduced
Compared with the manager's Q3 2024 13F
295,137
288,601
−2.2%
Share count drives classification; reported value also moves with price
2.47%
Within the filing's reported positions, not the manager's total assets
95
For Q4 2024
Congress
Traded Feb 25, 2025 · disclosed 30 days later
13 different filers disclosed TMO within 90 days.
Insider selling
Traded Mar 10, 2025 · filed 1 day laterNot reported under a pre-arranged trading plan
Thermo Fisher Scientific's SVP and General Counsel sold $2.01M of Thermo Fisher Scientific shares. The filing does not indicate a pre-arranged trading plan.
Marc N Casper (Chairman & CEO) sold ~$513K of Thermo Fisher Scientific
Planned saleEvery dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.